A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.
about
Precursors in cancer epidemiology: aligning definition and functionSeroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfectionRisk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.The association of HPV-16 seropositivity and natural immunity to reinfection: insights from compartmental modelsDeterminants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study.A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infectionCharacteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclassesHigh-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirusComparisons of VLP-Based ELISA, Neutralization Assays with Native HPV, and Neutralization Assays with PsV in Detecting HPV Antibody Responses in HIV-Infected WomenSeroprevalence and seroincidence of herpes simplex virus (2006-2010), syphilis (2006-2010), and vaccine-preventable human papillomavirus subtypes (2000-2010) among US military personnelHuman papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service.Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine typesDevelopment of a simple and quick immunochromatography method for detection of anti-HPV-16/-18 antibodies.Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in menConcordance and transmission of human papillomavirus within heterosexual couples observed over short intervalsNatural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis.Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.Updating the natural history of human papillomavirus and anogenital cancersA Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected SubjectsProphylactic HPV vaccination: past, present, and future.Antibody responses following incident anal and penile infection with human papillomavirus in teenage men who have sex with men.Concordance of HPV-DNA in cervical dysplasia or genital warts in women and their monogamous long-term male partners.Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study.Smoking and subsequent human papillomavirus infection: a mediation analysis.Naturally acquired immunity against human papillomavirus (HPV): why it matters in the HPV vaccine era.Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies
P2860
Q28387064-69A5C844-7A62-4D24-93EB-A621D00BFB2BQ33947813-EBC42415-09DC-4061-9328-A3569EFA5497Q33953881-68D771F2-A7E9-4100-BC6C-D411C1035760Q34542304-5843CF61-5344-4E25-AD65-CF7DEB5555A7Q34546550-2E2BB217-7EAA-4AF1-A2B5-9AE834E4262BQ34583160-33B067D8-04CD-4B43-89CC-DA317C3023D7Q34587057-B26DD768-4853-4684-A4BB-D3D219C0B568Q34970731-4C67275A-0ED4-48EB-AB57-5ACBD5C92986Q34994905-E2C36A9A-88B7-42AD-9E6C-F93911EBF3B8Q35016793-29CDE75B-0CBB-4504-A93E-F1780910BE12Q35109451-3E08454F-A10E-46AA-BD5C-B58B70F9BDBBQ35743769-AF485F0B-E049-470B-A774-0AAD8648C467Q35875215-F60BA5C1-506E-4616-9891-D7EC24B757DEQ35902322-22EAC16C-30CB-4FDC-810B-5BE08EEAEDC7Q36104074-ED8163AF-2C0D-4171-A153-20CAEA923440Q36269739-C6E0CE6A-15C9-417A-A082-474C0AE81C62Q36327051-DF30BB6A-15C0-46BB-AB61-FEAE52A08401Q36702619-392C12DF-E0B5-447B-902F-5664C899B67CQ36745242-5CA14310-987F-4A72-9422-D7FCFEB6BCF3Q36921606-50B7982F-4265-4446-A3D5-E466C92443EDQ36974917-388E2321-CD0B-4BAB-B271-759BED9ADD9DQ36979148-08994928-4CF4-4001-8D6A-E96E7F327B24Q37221868-CD9A9D31-D901-42DD-AB96-FE15BA54BD33Q38597567-48D9F6F0-D079-430D-BD2D-881D841009D5Q39908571-34254657-49A7-462E-B33A-825DEAB6ABFCQ40252265-680808E1-C7D4-4E21-812D-35915FAB25D8Q40571982-C32A57BA-D9CC-4F76-915E-5D2FB27AC273Q50137874-9934983D-2E1C-406F-B932-FE387BE3DFCCQ51103584-C3F18B26-8079-4280-B8D5-E5AEE07E293AQ58548093-6A98F21D-9B65-4319-8848-272609868CA1
P2860
A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A competitive serological assa ...... nacaste Natural History Study.
@ast
A competitive serological assa ...... nacaste Natural History Study.
@en
type
label
A competitive serological assa ...... nacaste Natural History Study.
@ast
A competitive serological assa ...... nacaste Natural History Study.
@en
prefLabel
A competitive serological assa ...... nacaste Natural History Study.
@ast
A competitive serological assa ...... nacaste Natural History Study.
@en
P2093
P2860
P50
P356
P1476
A competitive serological assa ...... nacaste Natural History Study.
@en
P2093
Arpita Ghosh
Diego Guillen
Jorge Morales
Mario Alfaro
Raphael Viscidi
Robert D Burk
Rolando Herrero
P2860
P304
P356
10.1093/INFDIS/JIR209
P407
P50
P577
2011-07-01T00:00:00Z